Kazuki Shiina

Prof. Dr. Kazuki Shiina

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2024 in Hypertension Research
Verified
Journal Article
Open access
PDF file
KSKazuki Shiina
Kazuki Shiina
Obstructive Sleep Apnea (OSA) and hypertension have a high rate of co-occurrence, with OSA being a causative factor for hypertension. Sympathetic activity due to intermittent hypoxia and/or fragmented sleep is the most important mechanisms triggering the elevation in blood pressure in OSA. OSA-related hypertension is characterized by resistant hypertension, nocturnal hypertension, abnormal blood pressure variability, and vascular remodeling. In particular, the prevalence of OSA is high in patients with resistant hypertension, and the mechanism proposed includes vascular remodeling due to the exacerbation of arterial stiffness by OSA. Continuous positive airway pressure therapy is effective at lowering blood pressure, however, the magnitude of the decrease in blood pressure is relatively modest, therefore, patients often need to also take antihypertensive medications to achieve optimal blood pressure control. Antihypertensive medications targeting sympathetic pathways or the renin-angiotensin-aldosterone system have theoretical potential in OSA-related hypertension, Therefore, beta-blockers and renin-angiotensin system inhibitors may be effective in the management of OSA-related hypertension, but current evidence is limited. The characteristics of OSA-related hypertension, such as nocturnal hypertension and obesity-related hypertension, suggests potential for angiotensin receptor-neprilysin inhibitor (ARNI), sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucose-dependent insulinotropic polypeptide receptor/ glucagon-like peptide-1 receptor agonist (GIP/GLP-1 RA). Recently, OSA has been considered to be caused not only by upper airway anatomy but also by several non-anatomic mechanisms, such as responsiveness of the upper airway response, ventilatory control instability, and reduced sleep arousal threshold. Elucidating the phenotypic mechanisms of OSA may potentially advance more personalized hypertension treatment strategies in the future.

29 June 2022 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
HNHiroki Nakano
Hiroki Nakano
KSKazuki Shiina
Kazuki Shiina
TTTakamichi Takahashi
Takamichi Takahashi
MFMasatsune Fujii
Masatsune Fujii
YIYoichi Iwasaki
Yoichi Iwasaki
HTHirofumi Tomiyama
Hirofumi Tomiyama
Background: Hypertension and diabetes frequently coexist; however, it has not yet been clarified if the bidirectional longitudinal relationships between arterial stiffness and hypertension are independent of those between arterial stiffness and diabetes. Methods and Results: In this 16‐year prospective observational study, 3960 middle‐aged employees of a Japanese company without hypertension/diabetes at the study baseline underwent annual repeated measurements of blood pressure, serum glycosylated hemoglobin A 1c levels, and brachial‐ankle pulse wave velocity. By the end of the study period, 664, 779, 154, and 406 subjects developed hypertension, prehypertension, diabetes, and prediabetes, respectively. Increased brachial‐ankle pulse wave velocity at the baseline was associated with a significant odds ratio (per 1 SD increase) for new onset of prehypertension/hypertension with (2.45/3.28; P <0.001) or without (2.49/2.76; P <0.001) coexisting prediabetes/diabetes, but not for new onset of prediabetes/diabetes without coexisting hypertension. Analyses using the latent growth curve model confirmed the bidirectional relationships between brachial‐ankle pulse wave velocity and hypertension, but no such relationship was observed between brachial‐ankle pulse wave velocity and abnormal glucose metabolism. Conclusions: In middle‐aged employees of a Japanese company, while bidirectional relationships were found to exist between increased arterial stiffness and hypertension, such a relationship was not found between increased arterial stiffness and diabetes. Therefore, it appears that increased arterial stiffness may be associated with the development of hypertension but not with that of diabetes.

15 February 2022 in Hypertension Research
Verified
Journal Article
Closed access
PDF file
KSKazuki Shiina
Kazuki Shiina
HTHirofumi Tomiyama
Hirofumi Tomiyama
ATAtsushi Tanaka
Atsushi Tanaka
HYHisako Yoshida
Hisako Yoshida
KEKazuo Eguchi
Kazuo Eguchi
TIthe PRIZE Study Investigators
the PRIZE Study Investigators

21 July 2011 in Sleep and Breathing
Verified
Journal Article
Closed access
PDF file
YUYasuhiro Usui
Yasuhiro Usui
YTYoshifumi Takata
Yoshifumi Takata
YIYuichi Inoue
Yuichi Inoue
KSKatsunori Shimada
Katsunori Shimada
HTHirofumi Tomiyama
Hirofumi Tomiyama
AYAkira Yamashina
Akira Yamashina

1 April 2017 in Journal of Cardiology
Verified
Journal Article
Closed access
SKShunsuke Komatsu
Shunsuke Komatsu
HTHirofumi Tomiyama
Hirofumi Tomiyama
KKKazutaka Kimura
Kazutaka Kimura
CMChisa Matsumoto
Chisa Matsumoto
KSKazuki Shiina
Kazuki Shiina
AYAkira Yamashina
Akira Yamashina

1 October 2023 in Hypertension
Verified
Journal Article
Closed access
HTHirofumi Tomiyama
Hirofumi Tomiyama
TITakumi Imai
Takumi Imai
KSKazuki Shiina
Kazuki Shiina
YHYukihito Higashi
Yukihito Higashi
HNHiroki Nakano
Hiroki Nakano
TCTaishiro Chikamori
Taishiro Chikamori
Background: Although some cardiovascular risk factors (CVRFs) are known to be associated with increased arterial stiffness, increased arterial stiffness does not mediate the cardiovascular risk associated with all CVRFs. Here, based on long-term repeated-measurement data, we examined the association of the lifelong status of each CVRF with the rate of progression of arterial stiffness. Methods: We utilized the data from annual health checkups with the brachial-ankle pulse wave velocity measurements over a 16-year period in middle-aged Japanese occupational cohort. Results: Totally, 29 090 brachial-ankle pulse wave velocity data were obtained during the follow-up of 3763 subjects ranging in age from around 30 to 70 years. Smoking, heavy alcohol intake, hypertension, diabetes, hypertriglyceridemia, and hyperuricemia were independently associated with the fast progression of arterial stiffness. Also, lower values in nondisease range in blood pressure, glycosylated hemoglobin A1c, triglyceride, and uric acid were independently associated with the slow progression of arterial stiffness. For body mass index and low-density lipoprotein cholesterol, no clear associations with the progression of arterial stiffness were observed. Conclusions: The present prospective study provided more robust epidemiological evidence for the heterogeneity of the significance of contribution of lifelong status of each CVRF to the slow and fast rate of progression of arterial stiffness. These findings suggest the important need to examine, in further studies, the effects of global early interventions to control the levels of the culprit CVRFs, even from middle age, not only to prevent a fast progression of the arterial stiffness but also to maintain a relatively slow progression of arterial stiffness.